Ongoing Challenges in the Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease

JAMA Neurol. 2023 Dec 1;80(12):1377-1379. doi: 10.1001/jamaneurol.2023.3956.
No abstract available

Plain language summary

This cross-sectional study examines whether proposed myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD) diagnostic criteria can exclude other diseases, such as multiple sclerosis, and rely on results of cell-based assays.

MeSH terms

  • Aquaporin 4
  • Autoantibodies*
  • Humans
  • Longitudinal Studies
  • Myelin-Oligodendrocyte Glycoprotein
  • Neuromyelitis Optica*

Substances

  • Myelin-Oligodendrocyte Glycoprotein
  • Autoantibodies
  • Aquaporin 4